Carol Linden Director Office of Regulatory Science and Innovation, FDA Dr. Linden currently serves as the Director, Office of Regulatory Science and Innovation in the Office of the Chief Scientist, Office of the Commissioner, U.S. Food and Drug Administration. There she oversees a broad array of both intramural and extramural programs focused on bringing understanding [...]
Adam Heathfield Senior Director Global Health and Value Innovation Center, Pfizer, UK Adam has worked for Pfizer for nine years. His current role is Senior Director in Pfizer’s Global Health and Value Innovation Center. Previously, Adam has worked in Pfizer’s international policy division and led Pfizer’s work on science policy in Europe for several years. [...]
October 22, 2015 – Washington D.C.
Vital Transformation is pleased to announce the Better Science, Better Health: New Healthcare Models Conference, which aims to promote international collaboration to accelerate new models in healthcare. Taking place in Washington D.C., from 27-28th October, the Conference features thought leaders who will help shape the future of healthcare in both Europe and the United States.
Better Science, Better Health: New Healthcare Models Join the conversation on Twitter #BSBH15 The Venues 1. Hotel George 15, E street, NW, Washington, DC 20001 2. Cannon House Office Building, Cannon Caucas Room 27 Independence Ave SE, Washington, DC 20003 Please use the visitor entrance; [...]
Jocelyn Ulrich, MPH Senior Director, Scientific and Regulatory Affairs, PhRMA Jocelyn B. Ulrich, MPH, RAC is Senior Director, Scientific and Regulatory Affairs at PhRMA, where she supports PhRMA’s policy advocacy strategies on clinical trials and innovative biologics and biosimilars. Prior to joining PhRMA, Jocelyn held positions of increasing responsibility at Pfizer and Human Genome Sciences [...]
Dr. Lynn D. Hudson Chief Science Officer for the Critical Path Institute (C-Path) and Executive Director of the Multiple Sclerosis Outcome Assessments Consortium Dr. Lynn D. Hudson serves as the Chief Science Officer for the Critical Path Institute (C-Path) and Executive Director of the Multiple Sclerosis Outcome Assessments Consortium. She started at C-Path by overseeing [...]
Sheldon Whitehouse United States Senator for Rhode Island Sheldon Whitehouse has made reforming our broken health care system a hallmark of his career. During his time as Rhode Island’s Attorney General he founded the Rhode Island Quality Institute, a collaborative effort between health care providers, insurers, and government that has pioneered efforts to expand the [...]
Peter L. Saltonstall President and CEO, NORD, Peter is NORD’s President and Chief Executive Officer. He has over 30 years of healthcare experience in both for-profit and not-for-profit environments, as well as extensive federal and commercial market knowledge. Peter has held senior positions within a number of major academic medical centers and organizations, including Harvard's [...]
Anders Olauson President, EPF Mr. Anders Olauson is founder, chairman and chief executive officer of the Agrenska Centre in Sweden. His vision behind setting up the Agrenska Centre in 1989 was his profound concern for children affected by rare conditions and their families and the need to move towards a fairer society that embraces and [...]
Nancy Berg CEO, ISPOR Nancy Berg has nearly 30 years of experience in health care, scientific, and technical association leadership, and has been an entrepreneur and business consultant to both commercial and nonprofit organizations. Ms Berg has been chief executive officer (CEO) and executive director of the International Society of Pharmacoeconomics and Outcomes Research (ISPOR) [...]